FIRST AIRED: June 17, 2015

Nice work! Enjoy the show!

×

You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!

We've got more news

Get our editor’s daily email summary of what’s going on in the world.

US Edition
Intl. Edition
Replay Program
0:00
0:00
More Info

COMING UP:Share Opener Variant 3

×

Transcript

00:00:00
the company that wiped unsightly wrinkles off millions around the world has a new target the dreaded double chin botox maker allergan agreed on wednesday to buy chi sara biopharmaceuticals as it readies a new injection aimed at cutting chicken fat , the injection called chi bella is the first and only non surgical treatment to stifle that sagging unwanted ripple the fact that so many people face , the price tag two point one billion dollars which breaks down to our organs paying seventy five dollars a share for chi sara a roughly twenty four percent premium took my fair share price at tuesday's market close , the deal is elegans first multi billion dollar acquisition since it was bought by drug maker activist last year , chi bella works by shooting a synthetic acid under the skin destroying fat cells while leaving the surrounding tissue unaffected , no price tags been revealed yet for the injection but chances are it's cheaper than liposuction which for double chins cost between twenty seven hundred dollars to upwards of five grand